The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment

Blood Cancer Journal, Published online: 02 August 2021; doi:10.1038/s41408-021-00530-3The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment

Source: Blood Cancer Journal - August 2, 2021 Category: Hematology Authors: Evangelos Terpos Maria Gavriatopoulou Ioannis Ntanasis-Stathopoulos Alexandros Briasoulis Sentiljana Gumeni Panagiotis Malandrakis Despina Fotiou Eleni-Dimitra Papanagnou Magdalini Migkou Foteini Theodorakakou Maria Roussou Evangelos Eleutherakis-Papaiako Source Type: research